GI
COGT icon

GAMMA Investing’s Cogent Biosciences COGT Stock Holding History

GAMMA Investing’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.4K Buy
1,303
+143
+12% +$5K ﹤0.01% 2289
2026
Q1 		$44.6K Sell
1,160
-209
-15% -$7.72K ﹤0.01% 2252
2025
Q4 		$48.6K Buy
1,369
+655
+92% +$18.4K ﹤0.01% 2094
2025
Q3 		$10.3K Buy
714
+412
+136% +$4.88K ﹤0.01% 2870
2025
Q2 		$2.17K Sell
302
-208
-41% -$1.15K ﹤0.01% 3381
2025
Q1 		$3.06K Buy
510
+147
+40% +$1.15K ﹤0.01% 3266
2024
Q4 		$2.83K Sell
363
-211
-37% -$2.1K ﹤0.01% 3112
2024
Q3 		$6.2K Buy
574
+452
+370% +$4.4K ﹤0.01% 2665
2024
Q2 		$1.03K Sell
122
-12
-9% -$91 ﹤0.01% 3055
2024
Q1 		$900 Sell
134
-77
-36% -$476 ﹤0.01% 2964
2023
Q4 		$935 Buy
+211
New +$1.62K ﹤0.01% 2809

Other funds holding COGT

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

GAMMA Investing's COGT Position: Q2 2026 in Review

GAMMA Investing increased its Cogent Biosciences (COGT) stake by 12% in Q2 2026, buying an estimated $5K and bringing the position to 1,303 shares worth $50.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2289.

GAMMA Investing first reported a position in COGT in Q4 2023 and has held it in 11 quarters since. 18 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • GAMMA Investing held 1,303 shares of Cogent Biosciences worth $50.4K as of Q2 2026.
  • GAMMA Investing bought 143 Cogent Biosciences shares in Q2 2026, an estimated $5K.
  • Cogent Biosciences made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2289 holding.
  • GAMMA Investing first reported a position in Cogent Biosciences in Q4 2023 and has held it in 11 quarters since.
  • 18 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.